cysteine has been researched along with charybdotoxin in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (60.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buresh, TL; Conklin, JL; Murray, JA; O'Meara, BW; Picken, H; Shibata, EF | 1 |
Kolmakova-Partensky, L; Miller, C; Shimony, E; Sun, T | 1 |
Dang, W; Kozlowski, E; Miller, C; Naini, AA; Shaikh, T; Shimony, E | 1 |
Aniort, V; Bouet, F; Drakopoulou, E; Ménez, A; Neyton, J; Virelizier, H; Vita, C; Vizzavona, J | 1 |
Barber, JE; Bradley, KK; Bradley, ME; Buxton, IL; McGaw, T | 1 |
Abassi, A; Ali, SA; Kayed, R; Schütz, J; Stoeva, S; Voelter, W; Zaidi, ZH | 1 |
Buxton, IL; Kaiser, RA; Malmquist, NA; Tichenor, S | 1 |
Jiang, M; Liu, J; Pardo-Lopez, L; Possani, LD; Tseng, GN; Zhang, M | 1 |
Chen, X; Ding, J; Li, H; Wu, G; Wu, H; Xu, T; Yao, J; Yao, L; Zhang, N; Zhou, Y; Zhou, Z | 1 |
Hua, Z; Kobertz, WR | 1 |
10 other study(ies) available for cysteine and charybdotoxin
Article | Year |
---|---|
Nitric oxide modulates a calcium-activated potassium current in muscle cells from opossum esophagus.
Topics: Animals; Calcium; Charybdotoxin; Cyclic GMP; Cysteine; Electric Conductivity; Electrophysiology; Esophagus; Female; Male; Muscle, Smooth; Nitric Oxide; Opossums; Potassium; S-Nitrosothiols; Thionucleotides | 1995 |
Engineering a uniquely reactive thiol into a cysteine-rich peptide.
Topics: Animals; Cells, Cultured; Charybdotoxin; Cysteine; Escherichia coli; Genetic Engineering; Models, Molecular; Neurotoxins; Oxidation-Reduction; Point Mutation; Potassium Channel Blockers; Potassium Channels; Protein Binding; Protein Folding; Recombinant Fusion Proteins; Rhodamines; Scorpion Venoms; Sulfhydryl Compounds; Sulfhydryl Reagents | 1994 |
Interaction of Ca2(+)-activated K+ channels with refolded charybdotoxins mutated at a central interaction residue.
Topics: Charybdotoxin; Cysteine; Escherichia coli; Large-Conductance Calcium-Activated Potassium Channels; Mutation; Ornithine; Potassium Channels; Potassium Channels, Calcium-Activated; Protein Binding; Protein Conformation; Protein Folding; Recombinant Fusion Proteins | 1996 |
Consequence of the removal of evolutionary conserved disulfide bridges on the structure and function of charybdotoxin and evidence that particular cysteine spacings govern specific disulfide bond formation.
Topics: Amino Acid Sequence; Animals; Charybdotoxin; Circular Dichroism; Conserved Sequence; Crystallography, X-Ray; Cysteine; Disulfides; Evolution, Molecular; Models, Molecular; Molecular Sequence Data; Muscle, Skeletal; Potassium Channel Blockers; Protein Conformation; Protein Folding; Rats; Structure-Activity Relationship | 1998 |
Nitric oxide relaxes human myometrium by a cGMP-independent mechanism.
Topics: Aminoquinolines; Charybdotoxin; Cyclic GMP; Cysteine; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; Methylene Blue; Myometrium; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; S-Nitrosothiols; Uterine Contraction | 1998 |
Purification and primary structure of low molecular mass peptides from scorpion (Buthus sindicus) venom.
Topics: Animals; Charybdotoxin; Chromatography, High Pressure Liquid; Cysteine; Molecular Sequence Data; Molecular Weight; Peptide Fragments; Scorpion Venoms; Scorpions; Sequence Homology, Amino Acid | 1998 |
NO-induced relaxation of labouring and non-labouring human myometrium is not mediated by cyclic GMP.
Topics: Charybdotoxin; Cyclic GMP; Cysteine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Guanylate Cyclase; Humans; In Vitro Techniques; Labor, Obstetric; Molsidomine; Muscle Relaxation; Muscle, Smooth; Myometrium; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Oxadiazoles; Oxytocin; Penicillamine; Peptides; Pregnancy; Quinoxalines; S-Nitrosothiols; Scorpion Venoms; Time Factors; Uterus | 2001 |
Mapping the binding site of a human ether-a-go-go-related gene-specific peptide toxin (ErgTx) to the channel's outer vestibule.
Topics: Amino Acid Sequence; Binding Sites; Calcium Channel Blockers; Cation Transport Proteins; Charybdotoxin; Cysteine; DNA-Binding Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Electrophysiology; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Hydrogen-Ion Concentration; Molecular Sequence Data; Mutagenesis, Site-Directed; Mutation; Oocytes; Potassium; Potassium Channels; Potassium Channels, Voltage-Gated; Protein Binding; Scorpion Venoms; Sequence Homology, Amino Acid; Shaker Superfamily of Potassium Channels; Tetraethylammonium; Time Factors; Trans-Activators; Transcriptional Regulator ERG | 2002 |
BmP09, a "long chain" scorpion peptide blocker of BK channels.
Topics: Adrenal Medulla; Amino Acid Sequence; Animals; Charybdotoxin; Chromatography; Cysteine; Disulfides; Dose-Response Relationship, Drug; Electrophysiology; Hydrogen Bonding; Kinetics; Large-Conductance Calcium-Activated Potassium Channels; Lysine; Methionine; Mice; Models, Molecular; Molecular Sequence Data; Mutagenesis; Oocytes; Patch-Clamp Techniques; Peptides; Potassium Channels, Calcium-Activated; Protein Structure, Tertiary; Scorpion Venoms; Scorpions; Sequence Homology, Amino Acid; Sodium; Sulfoxides; Time Factors; Xenopus | 2005 |
Chemical derivatization and purification of peptide-toxins for probing ion channel complexes.
Topics: Animals; Cells, Cultured; Charybdotoxin; Chromatography, Gel; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Cysteine; Hydrophobic and Hydrophilic Interactions; KCNQ1 Potassium Channel; Maleimides; Membrane Potentials; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Binding; Staining and Labeling | 2013 |